ALSA VENTURES
ALSA Ventures is a London based international life science investor focused on novel therapeutics.
ALSA VENTURES
Founded:
2019-01-01
Status:
Active
Technology used in webpage:
Euro Amazon
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Eternia Investments
Eternia Investments invest in companies that are run by good people who make great products.
Hamilton Venture Capital Ltd
Hamilton Ventures invests in and works with growth stage tech companies. We are about people, ideas and superior execution
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
New Industry Ventures
New Industry Ventures focuses on investments in technology companies specializing in the development of new materials.
Novartis Venture Fund
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.
Smartech Capital
They invest in technology companies creating innovative products with global ambition
Susten
Susten invest in the leading Energy Transition firms of the future with the knowledge, enthusiasm, and capital.
Current Employees Featured
Robert Balfour Investment Director @ ALSA Ventures
Investment Director
2018-07-01
Lorna Collings Chief Financial Officer @ ALSA Ventures
Chief Financial Officer
2019-11-01
Graeme Martin Chief Investment Officer @ ALSA Ventures
Chief Investment Officer
2019-04-01
Alek Safarian CEO @ ALSA Ventures
CEO
2018-01-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-09-19 | Axovia Therapeutics | Axovia Therapeutics acquired by ALSA Ventures | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-07-19 | Vantage Biosciences | ALSA Ventures investment in Seed Round - Vantage Biosciences | N/A |
| 2023-04-15 | Jatri | ALSA Ventures investment in Series A - Jatri | N/A |
| 2022-03-02 | Epsilogen | ALSA Ventures investment in Series B - Epsilogen | 30.75 M GBP |
| 2021-03-08 | Promatix | ALSA Ventures investment in Seed Round - Promatix | N/A |
| 2020-02-20 | Montis Biosciences | ALSA Ventures investment in Seed Round - Montis Biosciences | 8.4 M EUR |
More informations about "ALSA Ventures"
Meet the team - ALSA Ventures
Our team brings a rich background of pharmaceutical, biotechnology and CRO drug development expertise to companies we invest in.See details»
ALSA Ventures - Org Chart, Teams, Culture & Jobs | The Org
View ALSA Ventures' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
ALSA Ventures - Crunchbase Investor Profile & Investments
ALSA Ventures invest in biotechnology companies passionate about bringing novel therapies to patients.See details»
ALSA Ventures - LinkedIn
ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics. With a strong operations background in drug development, our team seeks to bring together ...See details»
ALSA Ventures' Leadership Team - Team members and org chart
The leadership team at ALSA Ventures has a history of experience in the pharmaceutical and healthcare industries, with members having served on the board oSee details»
ALSA Ventures
Jan 14, 2025 ALSA Ventures, Founded in 2019 by Alek Safarian, brings a Theyalth of experience from the pharmaceutical, BioTech, and clinical research organization (CRO) …See details»
Our approach - ALSA Ventures
Our investment approach is primarily focused around therapeutics. We look for novel drugs and modalities in a wide variety of disease area, and invest across the spectrum of drug development.See details»
ALSA Ventures – Startup Investor Profile – EasyVC
ALSA Ventures is a UK-based venture capital firm that focuses on investing in novel therapeutics across the pharmaceutical, biotechnology, and contract research organization (CRO) …See details»
ALSA Ventures today announced first closing of its European ...
London, UK – ALSA Ventures today announced first closing of its European biotechnology investment fund with commitments of US$59M. Established in 2019 by Alek Safarian, founder …See details»
ALSA Ventures - EU-Startups
ALSA Ventures invest in biotechnology companies passionate about bringing novel therapies to patients. ALSA Ventures is a life science venture capital investor, focused on early stage novel …See details»
On Your Mark: ALSA Ventures Lifts Early-Stage …
Oct 3, 2023 On Your Mark: ALSA Ventures Lifts Early-Stage European Biotechs to Jockey Out of the Gate This young UK-based VC launches and finances biotech companies focused on niche therapeutic developmentSee details»
ALSA Ventures investment portfolio | PitchBook
Founded in 2019, ALSA Ventures is a venture capital firm based in London, United Kingdom.See details»
ALSA Ventures - Investments, Portfolio & Company Exits
ALSA Ventures invest in biotechnology companies passionate about bringing novel therapies to patients.See details»
ALSA Ventures - teaserclub.com
ALSA Ventures is a London-based venture capital firm established in 2019, specializing in investments within the life sciences sector. The firm focuses on novel therapeutics and aims to …See details»
John Freidrich - Owner - ALM Ventures | LinkedIn
Owner, ALM Ventures · Experience: ALM Ventures · Location: Woodbridge. View John Freidrich’s profile on LinkedIn, a professional community of 1 billion members.See details»
More than 8,000 investors were misled by this $1.2B Ponzi scheme …
Jan 29, 2019 The SEC this week ordered alleged conductors of a Ponzi scheme to pay $1 billion in penalties and repayments. The move may help clear the way for 8,400 retail investors to …See details»
ALSA Ventures Appoints Dr. Bruce Goldsmith as Operating Partner
London, 28 January 2025 –ALSA Ventures, a London-based life sciences venture capital firm dedicated to building and growing early-stage biotech companies developing transformative …See details»
Driving Discovery: Canada’s role in the journey to Qalsody’s approval
19 hours ago After the genetic discovery, several Canadians funded by the ALS Canada Research Program played an important part in establishing SOD1’s dysfunction in ALS and …See details»
Omega Ventures LLC :: Virginia (US) :: OpenCorporates
Free and open company data on Virginia (US) company Omega Ventures LLC (company number S6447462), 12146 WINONA DRIVE, WOODRIDGE, Virginia, 22192-0000See details»
Eclipse - ALSA Ventures
The clinical development accelerator program ALSA Ventures has partnered with ICON Clinical Research to accelerate clinical development of novel compounds. Eclipse maximises the …See details»